These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28088342)

  • 1. Nanoparticle standards for immuno-based quantitation of α-synuclein oligomers in diagnostics of Parkinson's disease and other synucleinopathies.
    Herrmann Y; Bujnicki T; Zafiu C; Kulawik A; Kühbach K; Peters L; Fabig J; Willbold J; Bannach O; Willbold D
    Clin Chim Acta; 2017 Mar; 466():152-159. PubMed ID: 28088342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. sFIDA automation yields sub-femtomolar limit of detection for Aβ aggregates in body fluids.
    Herrmann Y; Kulawik A; Kühbach K; Hülsemann M; Peters L; Bujnicki T; Kravchenko K; Linnartz C; Willbold J; Zafiu C; Bannach O; Willbold D
    Clin Biochem; 2017 Mar; 50(4-5):244-247. PubMed ID: 27823959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-Synuclein as a Biomarker for Parkinson's Disease.
    Atik A; Stewart T; Zhang J
    Brain Pathol; 2016 May; 26(3):410-8. PubMed ID: 26940058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biofunctionalized Silica Nanoparticles: Standards in Amyloid-β Oligomer-Based Diagnosis of Alzheimer's Disease.
    Hülsemann M; Zafiu C; Kühbach K; Lühmann N; Herrmann Y; Peters L; Linnartz C; Willbold J; Kravchenko K; Kulawik A; Willbold S; Bannach O; Willbold D
    J Alzheimers Dis; 2016 Jul; 54(1):79-88. PubMed ID: 27472876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and Assessment of α-Synuclein Oligomers in the Urine of Parkinson's Disease Patients.
    Nam D; Lee JY; Lee M; Kim J; Seol W; Son I; Ho DH
    J Parkinsons Dis; 2020; 10(3):981-991. PubMed ID: 32444560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A FRET-based aptasensor for the detection of α-synuclein oligomers as biomarkers of Parkinson's disease.
    Saedi Z; Nikkhah M
    Anal Methods; 2022 Aug; 14(30):2937-2944. PubMed ID: 35861142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of α-synuclein oligomers in red blood cells as a potential biomarker of Parkinson's disease.
    Wang X; Yu S; Li F; Feng T
    Neurosci Lett; 2015 Jul; 599():115-9. PubMed ID: 25998655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naturally occurring alpha-synuclein autoantibodies in Parkinson's disease: sources of (error) variance in biomarker assays.
    Heinzel S; Gold M; Deuschle C; Bernhard F; Maetzler W; Berg D; Dodel R
    PLoS One; 2014; 9(12):e114566. PubMed ID: 25470145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Plasmonic Biosensor Utilizing Paired Antibody and Label-Free Fe
    Mandala SHS; Liu TJ; Chen CM; Liu KK; Januar M; Chang YF; Lai CS; Chang KH; Liu KC
    Biosensors (Basel); 2021 Oct; 11(10):. PubMed ID: 34677358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against alpha-synuclein: tools and therapies.
    Vaikath NN; Hmila I; Gupta V; Erskine D; Ingelsson M; El-Agnaf OMA
    J Neurochem; 2019 Sep; 150(5):612-625. PubMed ID: 31055836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of anticoagulants for blood-based quantitation of amyloid β oligomers in the sFIDA assay.
    Kravchenko K; Kulawik A; Hülsemann M; Kühbach K; Zafiu C; Herrmann Y; Linnartz C; Peters L; Bujnicki T; Willbold J; Bannach O; Willbold D
    Biol Chem; 2017 Apr; 398(4):465-475. PubMed ID: 27811340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies.
    Prots I; Grosch J; Brazdis RM; Simmnacher K; Veber V; Havlicek S; Hannappel C; Krach F; Krumbiegel M; Schütz O; Reis A; Wrasidlo W; Galasko DR; Groemer TW; Masliah E; Schlötzer-Schrehardt U; Xiang W; Winkler J; Winner B
    Proc Natl Acad Sci U S A; 2018 Jul; 115(30):7813-7818. PubMed ID: 29991596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinson's Disease.
    Vivacqua G; Latorre A; Suppa A; Nardi M; Pietracupa S; Mancinelli R; Fabbrini G; Colosimo C; Gaudio E; Berardelli A
    PLoS One; 2016; 11(3):e0151156. PubMed ID: 27011009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baicalein inhibits α-synuclein oligomer formation and prevents progression of α-synuclein accumulation in a rotenone mouse model of Parkinson's disease.
    Hu Q; Uversky VN; Huang M; Kang H; Xu F; Liu X; Lian L; Liang Q; Jiang H; Liu A; Zhang C; Pan-Montojo F; Zhu S
    Biochim Biophys Acta; 2016 Oct; 1862(10):1883-90. PubMed ID: 27425033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the current research on in vivo and in vitro detection for alpha-synuclein: a biomarker of Parkinson's disease.
    Wang R; Pang SC; Li JY; Li CL; Liu JM; Wang YM; Chen ML; Li YB
    Anal Bioanal Chem; 2023 Apr; 415(9):1589-1605. PubMed ID: 36688984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Synuclein in Parkinson's disease and advances in detection.
    Chen R; Gu X; Wang X
    Clin Chim Acta; 2022 Apr; 529():76-86. PubMed ID: 35176268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [α-Synuclein as Diagnostic Biomarker].
    Ono K
    Brain Nerve; 2020 Feb; 72(2):137-141. PubMed ID: 32036339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker.
    Visanji NP; Marras C; Hazrati LN; Liu LW; Lang AE
    Mov Disord; 2014 Apr; 29(4):444-50. PubMed ID: 24375496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
    Ohrfelt A; Grognet P; Andreasen N; Wallin A; Vanmechelen E; Blennow K; Zetterberg H
    Neurosci Lett; 2009 Feb; 450(3):332-5. PubMed ID: 19022350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosis.
    Parnetti L; Cicognola C; Eusebi P; Chiasserini D
    Biomark Med; 2016; 10(1):35-49. PubMed ID: 26643452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.